Skip to content

Clinical trials

Phase 1/2 Central Nervous System Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Central Nervous System Neoplasms Phase: Phase 1/2 Clear all

86 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200011
20014
20024
20033
20045
20056
20063
20072
20081
20093
20104
20111
20121
20132
20144
20162
20173
20181
20191
20203
20214
20223
20232
20241
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed51
Recruiting10
Terminated8
Active, not recruiting7
Unknown status6
Withdrawn4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins8
New Approaches to Brain Tumor Therapy Consortium7
Memorial Sloan Kettering Cancer Center5
Duke University4
National Cancer Institute (NCI)4
Radiation Therapy Oncology Group4
Alliance for Clinical Trials in Oncology3
Eli Lilly and Company2
Hoffmann-La Roche2
Jonsson Comprehensive Cancer Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Central Nervous System Neoplasms86
Glioblastoma47
Brain Neoplasms45
Gliosarcoma40
Astrocytoma29
Glioma24
Oligodendroglioma22
Neoplasms10
Medulloblastoma8
Recurrence8

Trials

Showing 51 to 75 of 86. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.